Systemic inflammatory response syndrome.
Despite advances in perinatal care in the past decade, sepsis and its complications continue to present problems for the neonate, remaining a major cause of neonatal morbidity and mortality. Sepsis research is focusing on how the neonate (host) responds to bacteria. The newborn may develop a systemic reaction to bacteria that induces the release of substances known as inflammatory mediators. Termed the systemic inflammatory response syndrome (SIRS), this reaction is believed to be responsible for the signs and symptoms of sepsis. This article introduces the neonatal nurse to SIRS, providing an overview of various inflammatory mediators and cytokines, their clinical consequences, and potential new therapies in the management of SIRS.
Botwinski
C A
CA
NICU, All Children's Hospital, St. Petersburg, Florida 33713, USA. Cab325@earthlink.net
D001777:Blood Coagulation / Q000502:physiology; D018450:Disease Progression; D006801:Humans; D007231:Infant, Newborn; D007249:Inflammation / Q000276:immunology; D018836:Inflammation Mediators / Q000502:physiology; D015931:Intensive Care, Neonatal / Q000379:methods; D017283:Neonatal Nursing / Q000379:methods; D012307:Risk Factors; D018746:Systemic Inflammatory Response Syndrome / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy
D018836:Inflammation Mediators